more_reports

Cannabis Company Forms Partnership to Develop Pharmaceuticals

10/06/2017

Additional Disclosures:

Echelon Wealth Partners, Emblem Corp., Oct. 4, 2017

ANALYST CERTIFICATION: Company: Emblem Corp.| EMC: TSXVI, Russell Stanley, hereby certify that the views expressed in this report accurately reflect my personal views about the subject securities or issuers. I also certify that I have not, am not, and will not receive, directly or indirectly, compensation in exchange for expressing the specific recommendations or views in this report.

Important Disclosures:
Has the Analyst had an onsite visit with the Issuer within the last 12 months? Yes. Visited production facility in Paris, Ontario on January 16th, 2017.